Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Hispanic patients with POAG had lower success rates after glaucoma surgery compared with patients of European descent
(Image credit: AdobeStock/Vladislav) A study reported lower success rates associated with initial trabeculectomy with mitomycin C (MMC) in Hispanic patients compared with those who were of European descent. This information may be useful when considering patient candidacy for glaucoma surgery,1…
Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series
Kicking off Northwestern University’s “Dinner with the Experts” series, Angelo P. Tanna, MD, leads a deep dive into OCT and perimetry for glaucoma progression on September 9, 2025. (Image credit: AdobeStock/FourLeafLover) As part of its new “Dinner with the Experts…
Alcon completes acquisition of LumiThera
(Image Credit: AdobeStock/Timon) Alcon has completed its planned acquisition of LumiThera, Inc, which was announced earlier in July of this year.1,2 According to Alcon, the acquisition includes the noninvasive Valeda photobiomodulation (PBM) device for the treatment of early and intermediate dry…
Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD
The Northwestern University Department of Ophthalmology is launching “Dinner with the Experts – Cases, Updates, and Clinical Pearls,” a collaborative space for sharing ophthalmic knowledge and practical takeaways. (Image credit: AdobeStock/Harsha) The Northwestern University Department of Ophthalmology is launching a…
Ashvattha reports positive phase 2 results for migaldendranib in DME and nAMD
(Image Credit: AdobeStock) Ashvattha Therapeutics shared positive topline data from its phase 2 study of migaldendranib (MGB) for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). The topline end-of-study results were announced at the 25th…
Contivue port delivery platform for nAMD receives CE mark
(Image credit: ©Symbiot/AdobeStock) The European Union has granted the EU CE mark to Roche’s port delivery platform, Contivue.1 This platform contains Susvimo (ranibizumab injection) 100 mg/mL, which is currently under review with the European Medicines Agency (EMA) for the treatment…
Creation of OpZira Inc. announced following Alcon’s acquisition of LumiThera
(Image credit: AdobeStock) The company OpZira Inc. has launched to advance ophthalmic diagnostics. The company plans to deliver innovative technologies with the ability to enhance the detection and monitoring of ocular disease, which can empower clinicians. Clark Tedford, PhD, President…
VirtuaLens launches virtual reality tool: Immersive IOL Simulator
(Image credit: AdobeStock/DeepView) VirtuaLens has launched its Immersive IOL Simulator. This is a virtual reality (VR) platform that is designed to allow cataract patients to explore and compare different intraocular lens (IOL) options before surgery. The company notes that the…
Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report
(Image Credit: AdobeStock/tadamichi) Sight Sciences announced that its TearCare System has been included in the new Dry Eye Workshop (DEWS) III report from the Tear Film and Ocular Surface Society (TFOS) published in the American Journal of Ophthalmology.1,2 This marks the…
Diabetic retinopathy in pregnancy
(Image credit: ©Wedding photography/AdobeStock) A recent nationwide registry study of women with type 1 diabetes, pregnant women, and retinopathy-matched, nonpregnant control participants had a similar risk of developing sight-threatening diabetic retinopathy (DR).1 The objective of the study was to evaluate…